Challenges in the Pharmacotherapeutic Management of Pediatric Asthma

Pharmaceuticals (Basel). 2022 Dec 18;15(12):1581. doi: 10.3390/ph15121581.

Abstract

Bronchial asthma is one of the most common chronic conditions in pediatric practice, with increasing prevalence hampered by poor socioeconomic impacts, leading to major public health issues. Considered as a complex heterogeneous syndrome, not a single disease, the management of the disease is a real challenge, impacting medical staff, patients and caregivers. Over the decades, a significant number of diagnostic and treatment regimen have been developed to achieve good standards, sustaining balanced control of the disease. This paper attempts a review on the establishment of new trends in the management of bronchial asthma in the pediatric age group.

Keywords: GINA; adolescent; child; pediatric bronchial asthma; treatment.

Publication types

  • Review

Grants and funding

This research received no external funding.